NCT04134936 - Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

February 11, 2021

Study Completion Date

August 10, 2022

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG

Tafasitamab

Six 21-day cycles of tafasitamab (12 mg/kg intravenously, on Day 1, 8 and 15) in addition to R-CHOP

DRUG

Tafasitamab plus lenalidomide

Six 21-day cycles of tafasitamab (12 mg/kg intravenously, on Day 1, 8 and 15) plus lenalidomide (starting dose 25 mg orally, on Day 1-10) in addition to R-CHOP

Trial Locations (70)

1090

MorphoSys Research Site, Vienna

MorphoSys Research Site, Brussels

2060

MorphoSys Research Site, Antwerp

2610

MorphoSys Research Site, Antwerp

3100

MorphoSys Research Site, Sankt Pölten

4010

MorphoSys Research Site, Linz

4600

MorphoSys Research Site, Wels

5020

MorphoSys Research Site, Salzburg

5530

MorphoSys Research Site, Yvoir

6020

MorphoSys Research Site, Innsbruck

6120

MorphoSys Research Site, Halle

8800

MorphoSys Research Site, Roeselare

9000

MorphoSys Research Site, Ghent

12808

MorphoSys Research Site, Prague

15006

MorphoSys Research Site, Prague

20037

MorphoSys Research Site, Washington D.C.

20850

MorphoSys Research Site, Rockville

29425

MorphoSys Research Site, Charleston

35391

MorphoSys Research Site, Giessen

37075

MorphoSys Research Site, Göttingen

40207

MorphoSys Research Site, Louisville

44106

MorphoSys Research Site, Cleveland

44137

MorphoSys Research Site, Dortmund

45236

MorphoSys Research Site, Cincinnati

50005

MorphoSys Research Site, Hradec Králové

52074

MorphoSys Research Site, Aachen

53127

MorphoSys Research Site, Bonn

55905

MorphoSys Research Site, Rochester

61801

MorphoSys Research Site, Urbana

70433

MorphoSys Research Site, Covington

73557

MorphoSys Research Site, Mutlangen

75246

MorphoSys Research Site, Dallas

75702

MorphoSys Research Site, Tyler

77030

MorphoSys Research Site, Houston

78240

MorphoSys Research Site, San Antonio

78705

MorphoSys Research Site, Austin

80012

MorphoSys Research Site, Aurora

80634

MorphoSys Research Site, München

81377

MorphoSys Research Site, München

85711

MorphoSys Research Site, Tucson

86156

MorphoSys Research Site, Augsburg

90419

MorphoSys Research Site, Nuremberg

91010

MorphoSys Research Site, Duarte

92024

MorphoSys Research Site, Encinitas

92801

MorphoSys Research Site, Anaheim

97080

MorphoSys Research Site, Würzburg

97401

MorphoSys Research Site, Eugene

98684

MorphoSys Research Site, Vancouver

06520

MorphoSys Research Site, New Haven

48109-5864

MorphoSys Research Site, Ann Arbor

A-8036

MorphoSys Research Site, Graz

708 52

MorphoSys Research Site, Ostrava

100 34

MorphoSys Research Site, Prague

Unknown

MorphoSys Research Site, Bordeaux

MorphoSys Research Site, Brest

MorphoSys Research Site, Nantes

MorphoSys Research Site, Pierre-Bénite

MorphoSys Research Site, Bologna

MorphoSys Research Site, Ravenna

MorphoSys Research Site, Barcelona

MorphoSys Research Site, Cáceres

MorphoSys Research Site, Girona

MorphoSys Research Site, Madrid

MorphoSys Research Site, Sabadell

MorphoSys Research Site, Seville

MorphoSys Research Site, Vitoria-Gasteiz

1099-023

MorphoSys Research Site, Lisbon

1400-038

MorphoSys Research Site, Lisbon

4200-072

MorphoSys Research Site, Porto

4200-319

MorphoSys Research Site, Porto